Catalyst Wire Dossier Catalyst Wire Dossier

CTLA-4 antibody

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CTLA-4 antibody, covering 2017-06-09 to 2025-04-16. Get the full timeline:

Most recent: Clinical Trial Update: PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment [Phase 2]

See pricing